FDA warning: some patients cannot process Plavix
12.03.10
WASHINGTON — The Food and Drug Administration is adding its strongest warning to the label for Plavix after reports that some patients cannot process the blockbuster blood thinner.
The FDA said in a statement Friday that certain patients with a genetic variation cannot metabolize the drug, putting them at increased risk for heart attack and stroke.
Patients can determine if they don't respond to Plavix by taking a genetic test. The FDA recommends non-responders use other blood thinners, such as aspirin.
The FDA previously added similar language to Plavix's label, but the new warning appears within a black box, the FDA's most severe safety warning.
Plavix is prescribed to heart disease patients to prevent dangerous blood clots, which can cause heart attack, stroke and death.
In order to work effectively, Plavix must be broken down by a particular liver enzyme. But FDA says 2 to 14 percent of people in the U.S. have low levels of the enzyme, preventing them from successfully processing Plavix. The likelihood of being a non-responder varies by race, according to the FDA.
Source: The Associated Press
Next Up In Do-Good Marketing: Brands Turn To Microsponsorships
01.03.10
Brands such as Quaker, Pepsi, Prilosec and Bisquick are moving beyond cause marketing to so-called microsponsorships that provide up to a few thousand dollars to consumers to fund their own pet projects, Natalie Zmuda and Emily Bryson York report.
The Pepsi Refresh program, through which consumers can apply for grants ranging from $5,000 to $250,000, is a prime example. Pepsi wants consumers choosing between a Coke and a Pepsi to think of the Refresh Project when they're about to buy. "It's that last three feet, that point of purchase," says Ralph Santana, vp-marketing at Pepsi. Pepsi is employing a "battery of diagnostics" to measure ROI, Santana says, and has partnered with third parties to ensure the quality and credibility of the program.
Experts say that the microsponsorship approach has its benefits, but warn that ROI is difficult to measure and say that it's challenging to match consumers' causes with the brand's promise. Plus, there are so many programs that
Source: Mediapost.com
Spring is upon us...
06.03.10
I realize it has been a while, and I apologize for not keeping you updated better lately... We have been busy here at Ricky Byers Racing, still trying to rustle up our primary sponsorship to get out on the track and make a difference by RACING FOR A CURE!
Ricky Byers Racing is very grateful to the associate sponsors who have already come alongside us in our endeavor to take a stand against cancer, including a new brand with which we are currently discussing partnership. Watch for a possible announcement about this exciting news soon!
Know that we have not given up, fans! Far from it! We have an entire team of dedicated folks hard at work trying to cover all aspects of achieving the goal to get me out there on the track to do what I know best... racing!
It does get frustrating, and I do have to fight being discouraged a lot of the time. I don't understand why it is so hard for some corporation
Source: NASCAR Ranting and Raving (blog)
-AstraZeneca's consummation of the second option will end the contingent payments in respect of Prilosec and Nexium and will effectively end AstraZeneca's
Then, about 8:45 pm, a man matching the same description stole 14 boxes of Prilosec and 15 boxes of Pepcid Complete from the CVS store at 1806 S. Ridgewood
BATAVIA, Ohio () -- Prilosec OTC has been an official sponsor of everything from Nascar to the Bunco parlor game and represented by
The US Food and Drug Administration (FDA) has new data showing that omeprazole (Prilosec/Prilosec OTC)—a medicine used to reduce stomach acid—reduces the